Laser safety: the need for protocols.


Journal

Cutis
ISSN: 2326-6929
Titre abrégé: Cutis
Pays: United States
ID NLM: 0006440

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 17 9 2020
pubmed: 18 9 2020
medline: 14 7 2021
Statut: ppublish

Résumé

Lasers are being used in ever-expanding roles in dermatology. As our understanding of laser energy grew, the need for safety guidelines became apparent. The US Food and Drug Administration (FDA) published the first safety guidelines in 1984, which are updated on a regular basis. However, these are just guidelines, and their implementation is voluntary by the laser practitioner. In this article, we discuss the 4 regulatory entities for laser safety in the United States, laser principles in general, ocular hazards, laser-generated airborne contaminants (LGACs), fires, and unintended laser beam injuries. We also review the use of checklists in reducing adverse outcomes and the need for safety protocols for laser practitioners. We provide a modifiable checklist, which pertains specifically to lasers and can be customized to meet the needs of the individual laser practitioner.

Identifiants

pubmed: 32941554
doi: 10.12788/cutis.0025
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-92

Auteurs

Caroline Daggett (C)

Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana; and Brookwood Baptist Health, Birmingham, Alabama. USA.

Amanda Daggett (A)

Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Elizabeth McBurney (E)

Department of Dermatology, Tulane University School of Medicine, New Orleans; Sanova Dermatology, Lafayette, Louisiana, USA.

Andrea Murina (A)

Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH